Did YOU get the jab?
No. I ended up getting the disease itself before I was able to get the jab. The ED doctor I saw to get the Eli Lily antibody therapy (bamlanivimab only) gave me a prescription for Ivermectin which I took. Just to give full disclosure. That is why I am not against people taking Ivermectin under a doctor's supervision. I knew it was not a well studied drug in the situation I was taking it. But I weighed side-effects of the drug and potential risks of taking it. I knew that Ivermectin had poor statistical evidence that it worked.
I also took vitamin C, zinc, quercetin, Vitamin D, melatonin and a multivitamin that has Thiamine in its formulation.
My adult children did not receive Ivermectin. I waited to see the effects on myself and their own response to the virus. They recovered on their own and did not need any extra treatment. Had they taken a turn for the worse I would likely have brought them to their doctor to discuss the use of Ivermectin.
I am not against people taking Ivermectin. I am against people overstating the evidence that Ivermectin works. My conclusion from this present study. We need a large trial of Ivermectin either here or in Europe or both to see if Ivermectin deserves widespread use.
As an example of how difficult these types of decisions are. The largest study (in terms of number of patients) included in the analysis of this study, that is the topic for this thread, was done in Columbia (the country not the university):
Lopez-Medina E. et al JAMA. 2021 Apr 13;325(14):1426-1435. doi: 10.1001/jama.2021.3071. Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial
"Conclusion and relevance: Among adults with mild COVID-19, a 5-day course of ivermectin, compared with placebo, did not significantly improve the time to resolution of symptoms. The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes."
This study was done in laboratory confirmed cases of COVID-19 and was double blinded and placebo controlled. It shows no effect over placebo.
This is the opposite of what the meta-analysis report concludes.
This underscores the importance of doing a large clinical trial to get the evidence we all hope will show a positive benefit for Ivermectin.